Why the study?
Stemless reverse total shoulder arthroplasty offers potential advantages such as bone stock preservation and reduced complications, but comprehensive evaluation of clinical outcomes was needed.
Does stemless reverse total shoulder arthroplasty improve shoulder function and provide safe outcomes in patients with shoulder disorders?
Does stemless reverse total shoulder arthroplasty improve shoulder function and provide safe outcomes in patients with shoulder disorders?
Stemless reverse total shoulder arthroplasty provides significant functional improvement with acceptable complication and revision rates.
Answers are grounded in this paper and cite their sources.
Supports consideration of stemless reverse TSA; extends pooled evidence but leaves randomized comparisons open.
Reverse total shoulder arthroplasty (rTSA) is increasingly being used as a reliable option for various shoulder disorders with deteriorated rotator cuff and glenohumeral joints. The stemless humerus component for shoulder arthroplasties is evolving with theoretical advantages, such as preservation of the humeral bone stock and decreased risk of periprosthetic fractures, as well as clinical research demonstrating less intraoperative blood loss, reduced surgical time, a lower rate of intraoperative fractures, and improved center of rotation restoration. In particular, for anatomical total shoulder arthroplasty (aTSA), the utilization of stemless humeral implants is gaining consensus in younger patients. The current systematic review of 14 clinical studies (637 shoulders) demonstrated the clinical outcomes of stemless rTSA. Regarding shoulder function, the mean Constant-Murley Score (CS) improved from 28.3 preoperatively to 62.8 postoperatively. The pooled overall complication and revision rates were 14.3% and 6.3%, respectively. In addition, recent studies have shown satisfactory outcomes with stemless rTSA relative to stemmed rTSA. Therefore, shoulder surgeons may consider adopting stemless rTSA, especially in patients with sufficient bone quality. However, further long-term studies comparing survivorship between stemless and stemmed rTSA are required to determine the gold standard for selecting stemless rTSA.
No takes yet. Share an insight, caveat, or question.
Hatta et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: